Intelligent Bio Solutions to Sell Up to $3.97M in Highly Dilutive ATM Offering Amidst Going Concern Warning
INBS is trading near its 52-week low of $3.28 (1.2% above the low).
Summary
Intelligent Bio Solutions announced plans to sell up to $3.97 million in common stock through an At-The-Market (ATM) offering, representing significant potential dilution for existing shareholders as the company faces a going concern warning and trades near 52-week lows.
Key Events · Financing and Capital Events · INBS
-
Capital Raise Update
The company updated its At-The-Market (ATM) offering, making up to $3,966,316 in common stock available for sale through Ladenburg Thalmann & Co. Inc. This is an update to an existing program established on September 18, 2024.
-
Significant Potential Dilution
The potential offering amount is substantial relative to the company's market capitalization, indicating a highly dilutive event for existing shareholders if fully utilized.
-
Critical Financial Need
The company explicitly stated a going concern warning in its latest 10-Q, highlighting the urgent need for this capital raise to fund operations and extend its financial runway.
-
Distressed Market Conditions
The offering is being conducted while the stock is trading near its 52-week low of $3.28, following a 1-for-10 reverse stock split in December 2025 to maintain Nasdaq listing compliance.
Analysis · INBS · Industrial Applications And Services
Intelligent Bio Solutions is updating its At-The-Market (ATM) offering, making available up to $3.97 million in common stock for sale. This capital raise is critical for the company's survival, as it explicitly disclosed a going concern warning in its recent 10-Q. The offering represents a substantial potential dilution for existing shareholders, especially considering the company's small market capitalization and the fact that its stock is trading near its 52-week low, following a recent reverse stock split. While the proceeds are intended for general working capital, the continuous nature of an ATM program creates an overhang on the stock price, and raising capital under such distressed conditions signals significant financial pressure.
At the time of this filing, INBS was trading at $3.32 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $3.28 to $24.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.